TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast Cancer
Clinical trial NCT01354522 · COMPLETED
Trial details
- NCT number
- NCT01354522
- Sponsor
- Peking Union Medical College Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2023-12-01
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.